IP Library Granted Patent US 11,168,340
Granted Patent B2
US 11,168,340 · App. 16/854,468 · Granted Nov 9, 2021

Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives

Inventors: Thomas W. Jeffries (Madison, WI); David Z. Mokry (Madison, WI); Christopher H. Calvey (Madison, WI)
Assignee: Xylome Corporation
C12P7/649C12N1/16C12N15/81C12P7/6463C12P21/00C12Q1/48C12Q1/527C12N15/1096C12P7/06C12Q1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,168,340
App. No.
16/854,468
Granted
Nov 9, 2021
Kind
B2
Abstract

Lipogenic yeasts bioengineered to overexpress genes for lipid production, and methods of use thereof. The yeasts are modified to express, constitutively express, or overexpress an acetyl-CoA carboxylase, an alpha-amylase, an ATP citrate lyase, a diacylglycerol acyltransferase, a fatty acid synthase, a glycerol kinase, a 6-phosphogluconate dehydrogenase, a glycerol-3-phosphate dehydrogenase, a malic enzyme, a fatty acyl-CoA reductase, a delta-9 acyl-CoA desaturase, a glycerol-3-phosphate acyltransferase, a lysophosphatidate acyltransferase, a glucose-6-phosphate dehydrogenase, a beta-glucosidase, a hexose transporter, a glycerol transporter, a glycoside hydrolase enzyme, an auxiliary activity family 9 enzyme, or combinations thereof. The yeasts in some cases are also modified to reduce or ablate activity of certain proteins. The methods include cultivating the yeast to convert low value soluble organic stillage byproducts into lipids suitable for biodiesel production and other higher value uses.

Claims (54)

1. A recombinant yeast comprising one or more recombinant genes, wherein the one or more recombinant genes are configured to express:

a diacylglycerol acyltransferase;

a malic enzyme; and

a glycerol-3-phosphate acyltransferase, wherein the glycerol-3-phosphate acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:40.

2. The recombinant yeast of claim 1 , wherein the yeast is a recombinant lipogenic yeast.

3. The recombinant yeast of claim 1 , wherein the yeast is a recombinant Lipomyces starkeyi.

4. The recombinant yeast of claim 1 , wherein the diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:14.

5. The recombinant yeast of claim 4 , wherein the one or more recombinant genes are further configured to express a second diacylglycerol acyltransferase, wherein the second diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:58.

6. The recombinant yeast of claim 1 , wherein the malic enzyme comprises a sequence at least about 90% identical to SEQ ID NO:34.

7. The recombinant yeast of claim 1 , wherein:

the diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:14;

the one or more recombinant genes are further configured to express a second diacylglycerol acyltransferase, wherein the second diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:58; and

the malic enzyme comprises a sequence at least about 90% identical to SEQ ID NO:34.

8. The recombinant yeast of claim 7 , wherein the yeast is a recombinant lipogenic yeast.

9. The recombinant yeast of claim 7 , wherein the yeast is a recombinant Lipomyces starkeyi.

10. The recombinant yeast of claim 1 , wherein the recombinant genes are further configured to express a glycerol-3-phosphate dehydrogenase.

11. A recombinant yeast comprising one or more recombinant genes, wherein the one or more recombinant genes are configured to express:

a diacylglycerol acyltransferase;

a malic enzyme;

a glycerol-3-phosphate acyltransferase; and

a glycerol-3-phosphate dehydrogenase, wherein the glycerol-3 -phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:32.

12. The recombinant yeast of claim 11 , wherein the one or more recombinant genes are further configured to express a second glycerol-3-phosphate dehydrogenase, wherein the second glycerol-3-phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:56.

13. The recombinant yeast of claim 11 , wherein the one or more recombinant genes are further configured to express a glycerol kinase.

14. A recombinant yeast comprising one or more recombinant genes, wherein the one or more recombinant genes are configured to express:

a diacylglycerol acyltransferase;

a malic enzyme;

a glycerol-3-phosphate acyltransferase;

a glycerol-3-phosphate dehydrogenase; and

a glycerol kinase, wherein the glycerol kinase comprises a sequence at least about 90% identical to SEQ ID NO:26.

15. The recombinant yeast of claim 14 , wherein:

the diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:14;

the one or more recombinant genes are further configured to express a second diacylglycerol acyltransferase, wherein the second diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:58;

the malic enzyme comprises a sequence at least about 90% identical to SEQ ID NO:34;

the glycerol-3-phosphate acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:40;

the glycerol-3-phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:32; and

the one or more recombinant genes are further configured to express a second glycerol-3- phosphate dehydrogenase, wherein the second glycerol-3-phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:56.

16. The recombinant yeast of claim 15 , wherein the yeast is a recombinant lipogenic yeast.

17. The recombinant yeast of claim 15 , wherein the yeast is a recombinant Lipomyces starkeyi.

18. The recombinant yeast of claim 10 , wherein the one or more recombinant genes are further configured to express an acetyl-CoA carboxylase.

19. The recombinant yeast of claim 18 , wherein the acetyl-CoA carboxylase comprises a sequence at least about 90% identical to SEQ ID NO:2.

20. A recombinant yeast comprising one or more recombinant genes, wherein the one or more recombinant genes are configured to express:

a diacylglycerol acyltransferase;

a malic enzyme;

a glycerol-3-phosphate acyltransferase;

a glycerol-3-phosphate dehydrogenase;

an acetyl-CoA carboxylase, wherein the acetyl-CoA carboxylase comprises a sequence at least about 90% identical to SEQ ID NO:2 and the acetyl-CoA carboxylase comprises a residue other than serine and threonine at a position corresponding to position 1146 of SEQ ID NO:2.

21. The recombinant yeast of claim 18 , wherein:

the diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:14;

the one or more recombinant genes are further configured to express a second diacylglycerol acyltransferase, wherein the second diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:58;

the malic enzyme comprises a sequence at least about 90% identical to SEQ ID NO:34;

the glycerol-3-phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:32; and

the acetyl-CoA carboxylase comprises a sequence at least about 90% identical to SEQ ID NO:2 and the acetyl-CoA carboxylase comprises a residue other than serine and threonine at a position corresponding to position 1146 of SEQ ID NO:2.

22. The recombinant yeast of claim 21 , wherein the yeast is a recombinant lipogenic yeast.

23. The recombinant yeast of claim 21 , wherein the yeast is a recombinant Lipomyces starkeyi.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2021
From: JEFFRIES, THOMAS W.; CALVEY, CHRISTOPHER H.; MOKRY, DAVID Z.
To: XYLOME CORPORATION
Reel/Frame 056072/0866 →
Continuity (3)
Continuation 15679825 · Aug 17, 2017
Provisional Application 62409126 · Oct 17, 2016
Related Publication 20200270651A1 · Aug 27, 2020